We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
California Water Service
CWT
$3.04B
| $32.9K | ﹤0.01% |
676
+470
| +228% | +$21.2K |
|
1652
Trinity Industries
TRN
$2.97B
| $32.9K | ﹤0.01% |
951
| – | – |
|
1653
StoneCo
STNE
$2.62B
| $32.9K | ﹤0.01% |
3,032
+1,068
| +54% | +$12.7K |
|
1654
Alignment Healthcare
ALHC
$4.02B
| $32.9K | ﹤0.01% |
1,380
+1,135
| +463% | +$21.8K |
|
1655
Regenxbio
RGNX
$623M
| $32.8K | ﹤0.01% |
2,741
+1,032
| +60% | +$8.56K |
|
1656
Bio-Techne
TECH
$11.2B
| $32.8K | ﹤0.01% |
464
-5,988
| -93% | -$323K |
|
1657
Kearny Financial
KRNY
$592M
| $32.7K | ﹤0.01% |
3,461
| – | – |
|
1658
Central Pacific Financial
CPF
$997M
| $32.7K | ﹤0.01% |
857
-13
| -1% | -$452 |
|
1659
Cohen & Steers
CNS
$4.18B
| $32.7K | ﹤0.01% |
429
+121
| +39% | +$8.56K |
|
1660
United States Lime & Minerals
USLM
$3.18B
| $32.7K | ﹤0.01% |
312
+9
| +3% | +$1.04K |
|
1661
WesBanco
WSBC
$3.95B
| $32.6K | ﹤0.01% |
836
| – | – |
|
1662
ESCO Technologies
ESE
$8.49B
| $32.6K | ﹤0.01% |
93
| – | – |
|
1663
Hawkins
HWKN
$2.91B
| $32.5K | ﹤0.01% |
229
+10
| +5% | +$1.58K |
|
1664
Marcus Corp
MCS
$732M
| $32.5K | ﹤0.01% |
1,387
| – | – |
|
1665
Towne Bank
TOWN
$3.35B
| $32.5K | ﹤0.01% |
897
| – | – |
|
1666
Tetra Tech
TTEK
$8.23B
| $32.4K | ﹤0.01% |
1,121
-9,449
| -89% | -$277K |
|
1667
Shenandoah Telecom
SHEN
$632M
| $32.3K | ﹤0.01% |
2,140
-166
| -7% | -$2.61K |
|
1668
NovaGold Resources
NG
$2.6B
| $32.2K | ﹤0.01% |
5,399
+754
| +16% | +$6.27K |
|
1669
Mueller Water Products
MWA
$3.92B
| $32.2K | ﹤0.01% |
1,247
| – | – |
|
1670
Pegasystems
PEGA
$4.41B
| $32.2K | ﹤0.01% |
1,074
-2,108
| -66% | -$75.4K |
|
1671
Koppers
KOP
$966M
| $32.1K | ﹤0.01% |
715
-14
| -2% | -$573 |
|
1672
Nicolet Bankshares
NIC
$3.57B
| $32.1K | ﹤0.01% |
194
+24
| +14% | +$3.54K |
|
1673
Northeast Bank
NBN
$1.11B
| $32.1K | ﹤0.01% |
242
-7
| -3% | -$866 |
|
1674
Ingersoll Rand
IR
$33B
| $32.1K | ﹤0.01% |
391
-556
| -59% | -$43K |
|
1675
Triumph Financial Inc
TFIN
$1.84B
| $32K | ﹤0.01% |
420
+75
| +22% | +$5.1K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.